Your email has been successfully added to our mailing list.

×
0.0550790332349896 0.0550790332349896 0.0550790332349896 0.0550790332349896 0.0515621031242063 0.0492174830503507 0.0597878118833161 0.0624450479670191
Stock impact report

INmune Bio Announces Final Phase I Clinical Data for its Soluble TNF Inhibitor, INB03, Demonstrates Efficacy and Safety; INB03 is Advancing to Phase II Trials

INmune Bio Inc. - Common stock (INMB) 
Company Research Source: GlobeNewswire
Phase II program to focus on women with trastuzumab resistant HER2+ breast cancer LA JOLLA, Calif. , Dec. 17, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc., an immunology company developing therapies that reprogram the patient’s innate immune system to treat diseases, today announced that it has successfully completed the Phase I trial of INB03 and the database has been locked.  The Phase I trial was an open-label, dose-escalation trial in patients with advanced solid tumors.  “This was our first trial of the DN-TNF platform in patients, and we are pleased with the safety and efficacy results,” said RJ Tesi, MD, CEO and CMO of INmune Bio.   “This milestone now allows us to move the trial to Phase II in cancer and leverage our data into other programs for our DN-TNF platform.” Key Findings: 1 mg/kg was selected as the recommended Phase II dose for further studies.Across all cancer subsets, INB03 showed no toxicities or serious adverse events and was well tolerated.The inflammatory cyt Show less Read more
Impact Snapshot
Event Time:
INMB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for INMB alerts
Opt-in for
INMB alerts

from News Quantified
Opt-in for
INMB alerts

from News Quantified